REGENXBIO (RGNX) IPO Prices In-Line at $22
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/19/2026
- S&P 500, Nasdaq futures rise as AI stocks rebound ahead of key earnings
- U.S. economy is "booming," JPMorgan’s Dimon says
- Oil slips from 5-month high as Trump's Russia sanctions waiver may bring more supplies
- Prepare to buy the dip as U.S. stock selloff nears its end: Morgan Stanley
- Goldman warns high investor conviction could amplify volatility as sentiment shift
- Brazil's Bolsonaro, Lula spar in first debate as personal attacks fly
- Microsoft pulls out of UK data center deal with Nscale, Telegraph reports
- Lithuanians forced to take shelter after suspected drone enters airspace
- Oil slips from 5-month high as Trump's Russia sanctions waiver may bring more supplies
REGENXBIO (RGNX) IPO Opens Up 38%
September 17, 2015 11:06 AM EDTToday's IPO for REGENXBIO Inc. (NASDAQ: RGNX) opened for trading at $30.26 after pricing 6,300,000 shares of its common stock at a public offering price of $22.00 per share, inline with the expected pricing. The number of shares offered was raised from 5,555,555 shares.
In addition, REGENXBIO granted the underwriters a 30-day option... More



